REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 171 filers reported holding REVOLUTION MEDICINES INC in Q3 2023. The put-call ratio across all filers is 0.54 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,281,755 | -27.7% | 226,942 | -30.2% | 0.04% | -24.5% |
| Q2 2023 | $8,692,225 | +22.5% | 324,943 | -0.8% | 0.05% | +2.1% |
| Q1 2023 | $7,095,513 | +25.5% | 327,586 | +38.0% | 0.05% | +2.1% |
| Q4 2022 | $5,652,915 | +7.0% | 237,318 | -11.4% | 0.05% | -16.1% |
| Q3 2022 | $5,282,000 | +163.2% | 267,853 | +160.0% | 0.06% | +211.1% |
| Q2 2022 | $2,007,000 | -47.1% | 103,001 | -30.7% | 0.02% | -18.2% |
| Q1 2022 | $3,791,000 | -4.4% | 148,622 | -5.7% | 0.02% | +4.8% |
| Q4 2021 | $3,965,000 | +45.2% | 157,533 | +58.7% | 0.02% | +10.5% |
| Q3 2021 | $2,731,000 | +13.0% | 99,276 | +30.4% | 0.02% | +26.7% |
| Q2 2021 | $2,416,000 | -24.8% | 76,114 | +8.7% | 0.02% | -31.8% |
| Q1 2021 | $3,213,000 | +406.0% | 70,040 | +336.4% | 0.02% | +266.7% |
| Q4 2020 | $635,000 | -1.2% | 16,048 | -13.2% | 0.01% | -25.0% |
| Q3 2020 | $643,000 | – | 18,483 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nextech Invest Ltd. | 4,839,529 | $133,958,163 | 40.59% |
| Column Group LLC | 1,230,641 | $34,064,143 | 22.62% |
| Boxer Capital, LLC | 4,684,264 | $129,660,428 | 6.90% |
| Finepoint Capital LP | 427,000 | $11,819,360 | 5.89% |
| Casdin Capital, LLC | 1,810,000 | $50,100,800 | 5.54% |
| EcoR1 Capital, LLC | 5,577,863 | $154,395,248 | 5.21% |
| DAFNA Capital Management LLC | 473,394 | $13,103,546 | 4.08% |
| Artal Group S.A. | 2,529,737 | $70,023 | 3.00% |
| BVF INC/IL | 3,981,212 | $110,199,948 | 2.97% |
| Bellevue Group AG | 4,721,500 | $130,691,120 | 2.11% |